The intensity of internalization and cytotoxicity of superparamagnetic iron oxide nanoparticles with different surface modifications in human tumor and diploid lung cells

Neoplasma

Volumn 59, Issue 5, 2012, Pages 584-597

  Mesarosova, M ^a   Ciampor, F ^a   Zavisova, V ^a   Koneracka, M ^a   Ursinyova, M ^b   Kozics, K ^a   Tomasovicova, N ^a   Hashim, A ^a   Vavra, I ^a   Krizanova, Z ^a   Husekova, Z ^b   Kubovcikova, M ^a   Kopcansky, P ^a   Timko, M ^a   Gabelova, A ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

Cellular uptake; Cytotoxicity; Magnetite nanoparticles; Surface modifications

Indexed keywords

FERRIC FERROCYANIDE; LACTATE DEHYDROGENASE; MACROGOL; OLEATE SODIUM; POLYGLACTIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TRYPAN BLUE; FERRIC ION; FERRIC OXIDE; MAGNETITE NANOPARTICLE;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CELL ULTRASTRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIPLOIDY; DRUG STRUCTURE; EMBRYO; EMBRYO CELL; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; INTERNALIZATION; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL; MAGNETOMETER; MASS SPECTROMETRY; NEOPLASM; PARTICLE SIZE; STAINING; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ADENOCARCINOMA; ANIMAL EMBRYO; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG DELIVERY SYSTEM; DRUG EFFECT; LUNG; LUNG TUMOR; PATHOLOGY;

ADENOCARCINOMA; CELL PROLIFERATION; CELLS, CULTURED; DIPLOIDY; DRUG DELIVERY SYSTEMS; EMBRYO, MAMMALIAN; FERRIC COMPOUNDS; HUMANS; LUNG; LUNG NEOPLASMS; MAGNETITE NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES;

EID: 84866765903     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2012_075     Document Type: Article

References (55)

1. SINGH N, MANSHIAN B, JENKINS GJ, GRIFFITHS SM, WILLIAMS PM et al. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 2009; 30: 3891-3914. http://dx.doi.org/10.1016/j.biomaterials.2009.04.009
2. JORDAN A, SCHLOZ R, MAIER-HAUFF K, JOHANNSEN M, WUST P et al. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J Magn Magn Mater 2001; 225: 118-126. http://dx.doi.org/10.1016/S0304-8853(00)01239-7
3. TORCHILIN VP. Drug targeting. Eur J Pharm Sci 2000; 11 Suppl 2: S81-S91. http://dx.doi.org/10.1016/S0928-0987(00)00166-4
4. SINGH N, MANSHIAN B, JENKINS GJ, GRIFFITHS SM, WILLIAMS PM et al. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 2009; 30: 3891-3914. http://dx.doi.org/10.1016/j.biomaterials.2009.04.009
5. JORDAN A, SCHLOZ R, MAIER-HAUFF K, JOHANNSEN M, WUST P et al. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J Magn Magn Mater 2001; 225: 118-126. http://dx.doi.org/10.1016/S0304-8853(00)01239-7
6. TORCHILIN VP. Drug targeting. Eur J Pharm Sci 2000; 11 Suppl 2: S81-S91. http://dx.doi.org/10.1016/S0928-0987(00)00166-4
7. XIANG JJ, TANG JQ, ZHU SG, NIE XM, LU HB et al. IONPPLL: a novel non-viral vector for efficient gene delivery. J Gene Med 2003; 5: 803-817. http://dx.doi.org/10.1002/jgm.419
8. LUBBE AS, BERGEMANN C, RIESS H, SCHRIEVER F, REICHARDT P et al. Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 10-15-1996; 56: 4686-4693.
9. MARSZALL MP. Application of magnetic nanoparticles in pharmaceutical sciences. Pharm Res 2011; 28: 480-483. http://dx.doi.org/10.1007/s11095-010-0284-6
10. KIM JS, YOON TJ, YU KN, NOH MS, WOO M et al. Cellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cells. J Vet Sci 2006; 7: 321-326. http://dx.doi.org/10.4142/jvs.2006.7.4.321
11. GUPTA AK, GUPTA M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005; 26: 3995-4021. http://dx.doi.org/10.1016/j.biomaterials.2004.10.012
12. ZHANG Y, KOHLER N, ZHANG M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002; 23: 1553-1561. http://dx.doi.org/10.1016/S0142-9612(01)00267-8
13. BABIC M, HORAK D, TRCHOVA M, JENDELOVA P, GLOGAROVA K et al. Poly(l-lysine)-Modified Iron Oxide Nanoparticles for Stem Cell Labeling. Bioconjug Chem 2-21-2008; 19: 740-750.
14. KEMENY NE, NIEDZWIECKI D, HOLLIS DR, LENZ HJ, WARREN RS et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 2006; 24: 1395-1403. http://dx.doi.org/10.1200/JCO.2005.03.8166
15. SALOMON JJ, EHRHARDT C. Nanoparticles attenuate P-glycoprotein/MDR1 function in A549 human alveolar epithelial cells. Eur J Pharm Biopharm 2011; 77: 392-397. http://dx.doi.org/10.1016/j.ejpb.2010.11.009
16. GUERIN C, OLIVI A, WEINGART JD, LAWSON HC, BREM H. Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. Invest New Drugs 2004; 22: 27-37. http://dx.doi.org/10.1023/B:DRUG.0000006172.65135.3e
17. GAGNADOUX F, HUREAUX J, VECELLIO L, URBAN T, LE PAPE A et al. Aerosolized chemotherapy. J Aerosol Med Pulm Drug Deliv 2008; 21: 61-70. http://dx.doi.org/10.1089/jamp.2007.0656
18. FOSTER KA, OSTER CG, MAYER MM, AVERY ML, AUDUS KL. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res 1998; 243: 359-366. http://dx.doi.org/10.1006/excr.1998.4172
19. SPORTY JL, HORALKOVA L, EHRHARDT C. In vitro cell culture models for the assessment of pulmonary drug disposition. Expert Opin Drug Metab Toxicol 2008; 4: 333-345. http://dx.doi.org/10.1517/17425255.4.4.333
20. MANSOUR HM, RHEE YS, WU X. Nanomedicine in pulmonary delivery. Int J Nanomedicine 2009; 4: 299-319.
21. BORM PJ, ROBBINS D, HAUBOLD S, KUHLBUSCH T, FISSAN H et al. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 2006; 3: 11. http://dx.doi.org/10.1186/1743-8977-3-11
22. BECK-BROICHSITTER M, SCHWEIGER C, SCHMEHL T, GESSLER T, SEEGER W et al. Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery. J Control Release 2011.
23. CARVALHO TC, CARVALHO SR, MCCONVILLE JT. Formulations for pulmonary administration of anticancer agents to treat lung malignancies. J Aerosol Med Pulm Drug Deliv 2011; 24: 61-80. http://dx.doi.org/10.1089/jamp.2009.0794
24. ZAVISOVA V, KONERACKA M, STRBAK O, TOMASOVICOVA N, KOPCANSKY P et al. Encapsulation of indomethacin in magnetic biodegradable polymer nanoparticles. J Mag Mag Mater 2007; 311: 379-382. http://dx.doi.org/10.1016/j.jmmm.2006.11.177
25. ZAVISOVA V, KONERACKA M, MUCKOVA M, LAZOVA J, JURIKOVA A et al. Magnetic fluid poly(ethylene glycol) with moderate anticancer activity. J Mag Mag Mater 2011; 323: 1408-1412. http://dx.doi.org/10.1016/j.jmmm.2010.11.060
26. FESSI H, PUISIEUX F, DEVISSAGUET JP, AMMOURY N, BENITA S. Nanocapsules formation by interfacial deposition following solvent displacement. Int J Pharm 1989; 55: R1-R4. http://dx.doi.org/10.1016/0378-5173(89)90281-0
27. KONERACKA M, MUCKOVA M, ZAVISOVA V, TOMASOVICOVA N, KOPCANSKY P et al. Encapsulation of anticancer drug and magnetic particles in biodegradable polymer nanospheres. J Phys Condens Matter 2008; 20: 204151. http://dx.doi.org/10.1088/0953-8984/20/20/204151
28. MOSMANN T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63. http://dx.doi.org/10.1016/0022-1759(83)90303-4
29. HAFELI UO, RIFFLE JS, HARRIS-SHEKHAWAT L, CARMICHAEL-BARANAUSKAS A, MARK F et al. Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol Pharm 2009; 6: 1417-1428. http://dx.doi.org/10.1021/mp900083m
30. HAMILTON JA, GUO W, KAMP F. Mechanism of cellular uptake of long-chain fatty acids: Do we need cellular proteins? Mol Cell Biochem 2002; 239: 17-23. http://dx.doi.org/10.1023/A:1020542220599
31. YIN H, TOO HP, CHOW GM. The effects of particle size and surface coating on the cytotoxicity of nickel ferrite. Biomaterials 2005; 26: 5818-5826. http://dx.doi.org/10.1016/j.biomaterials.2005.02.036
32. MARTINEZ-PALOMO A, BRAISLOVSKY C, BERNHARD W. Ultrastructural modifications of the cell surface and intercellular contacts of some transformed cell strains. Cancer Res 1969; 29: 925-937.
33. LANDSIEDEL R, MA-HOCK L, KROLL A, HAHN D, SCHNEKENBURGER J et al. Testing metal-oxide nanomaterials for human safety. Adv Mater 2010; 22: 2601-2627. http://dx.doi.org/10.1002/adma.200902658
34. PETRI-FINK A, STEITZ B, FINKA A, SALAKLANG J, HOFMANN H. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies. Eur J Pharm Biopharm 2008; 68: 129-137. http://dx.doi.org/10.1016/j.ejpb.2007.02.024
35. RUH H, KUHL B, BRENNER-WEISS G, HOPF C, DIABATE S et al. Identification of serum proteins bound to industrial nanomaterials. Toxicol Lett 2012; 208: 41-50. http://dx.doi.org/10.1016/j.toxlet.2011.09.009
36. AGGARWAL P, HALL JB, MCLELAND CB, DOBROVOLSKAIA MA, MCNEIL SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 2009; 61: 428-437. http://dx.doi.org/10.1016/j.addr.2009.03.009
37. SINGH N, JENKINS GJ, NELSON BC, MARQUIS BJ, MAFFEIS TG et al. The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticles. Biomaterials 2012; 33: 163-170. http://dx.doi.org/10.1016/j.biomaterials.2011.09.087
38. LYNCH I, CEDERVALL T, LUNDQVIST M, CABALEIRO-LAGO C, LINSE S et al. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci 2007; 134-135: 167-174. http://dx.doi.org/10.1016/j.cis.2007.04.021
39. CEDERVALL T, LYNCH I, LINDMAN S, BERGGARD T, THULIN E et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 2007; 104: 2050-2055. http://dx.doi.org/10.1073/pnas.0608582104
40. DUTTA D, SUNDARAM SK, TEEGUARDEN JG, RILEY BJ, FIFIELD LS et al. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci 2007; 100: 303-315. http://dx.doi.org/10.1093/toxsci/kfm217
41. THODE K, LUCK M, SEMMLER W, MULLER RH, KRESSE M. Determination of plasma protein adsorption on magnetic iron oxides: sample preparation. Pharm Res 1997; 14: 905-910. http://dx.doi.org/10.1023/A:1012104017761
42. GESSNER A, LIESKE A, PAULKE BR, MULLER RH. Functional groups on polystyrene model nanoparticles: influence on protein adsorption. J Biomed Mater Res A 2003; 65: 319-326. http://dx.doi.org/10.1002/jbm.a.10371
43. PETROS RA, DESIMONE JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010; 9: 615-627. http://dx.doi.org/10.1038/nrd2591
44. MARANO F, HUSSAIN S, RODRIGUES-LIMA F, BAEZASQUIBAN A, BOLAND S. Nanoparticles: molecular targets and cell signalling. Arch Toxicol 2011; 85: 733-741. http://dx.doi.org/10.1007/s00204-010-0546-4
45. YANG CY, TAI MF, LIN CP, LU CW, WANG JL et al. Mechanism of cellular uptake and impact of ferucarbotran on macrophage physiology. PLoS One 2011; 6: e25524. http://dx.doi.org/10.1371/journal.pone.0025524
46. CHOI JY, LEE SH, NA HB, AN K, HYEON T et al. In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines. Bioprocess Biosyst Eng 2010; 33: 21-30. http://dx.doi.org/10.1007/s00449-009-0354-5
47. GE Y, ZHANG Y, XIA J, MA M, HE S et al. Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro. Colloids Surf B Biointerfaces 2009; 73: 294-301. http://dx.doi.org/10.1016/j.colsurfb.2009.05.031
48. LEWINSKI N, COLVIN V, DREZEK R. Cytotoxicity of nanoparticles. Small 2008; 4: 26-49. http://dx.doi.org/10.1002/smll.200700595
49. MA YJ, GU HC. Study on the endocytosis and the internalization mechanism of aminosilane-coated Fe3O4 nanoparticles in vitro. J Mater Sci Mater Med 2007; 18: 2145-2149. http://dx.doi.org/10.1007/s10856-007-3015-8
50. KEMP SJ, THORLEY AJ, GORELIK J, SECKL MJ, O'HARE MJ et al. Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake. Am J Respir Cell Mol Biol 2008; 39: 591-597. http://dx.doi.org/10.1165/rcmb.2007-0334OC
51. NGUYEN J, REUL R, BETZ T, DAYYOUB E, SCHMEHL T et al. Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improve transfection efficiency to lung cells. J Control Release 2009; 140: 47-54. http://dx.doi.org/10.1016/j.jconrel.2009.07.017
52. ORR G, PANTHER DJ, PHILLIPS JL, TARASEVICH BJ, DOHNALKOVA A et al. Submicrometer and nanoscale inorganic particles exploit the actin machinery to be propelled along microvilli-like structures into alveolar cells. ACS Nano 2007; 1: 463-475. http://dx.doi.org/10.1021/nn700149r
53. PERUMAL OP, INAPAGOLLA R, KANNAN S, KANNAN RM. The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials 2008; 29: 3469-3476.
54. HARUSH-FRENKEL O, BIVAS-BENITA M, NASSAR T, SPRINGER C, SHERMAN Y et al. A safety and tolerability study of differently-charged nanoparticles for local pulmonary drug delivery. Toxicol Appl Pharmacol 2010; 246: 83-90. http://dx.doi.org/10.1016/j.taap.2010.04.011
55. YING E, HWANG H-M. In vitro evaluation of the cytotoxicity of iron oxide nanoaprticles with different coatings and different sizes in A3 human T lymphocytes. Science Of The Total Environment 2010; 408: 4475-4481. http://dx.doi.org/10.1016/j.scitotenv.2010.07.025